Hesperidin Alleviates Lipopolysaccharide-Induced Neuroinflammation in Mice by Promoting the miRNA-132 Pathway

Inflammation

Volumn 39, Issue 5, 2016, Pages 1681-1689

  Li, Min ^a   Shao, Huanzhang ^a   Zhang, Xia ^a   Qin, Bingyu ^a  

^a Henan Province Hospital   (China)

Author keywords

Antidepressant; Hesperidin; Lipopolysaccharide (LPS); miRNA 132; Pro inflammatory cytokines

Indexed keywords

ANTAGOMIR; CORTICOSTERONE; FLUOXETINE; HESPERIDIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MICRORNA 132; TUMOR NECROSIS FACTOR; ANTIDEPRESSANT AGENT; CYTOKINE; MICRORNA; MIRN132 MICRORNA, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDEPRESSANT ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DEPRESSION; DOWN REGULATION; DRUG MECHANISM; EXPERIMENTAL INFLAMMATION; FORCED SWIM TEST; GENE EXPRESSION REGULATION; LIPOPOLYSACCHARIDE INDUCED NEUROINFLAMMATION; LOCOMOTION; MALE; MOUSE; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; OPEN FIELD TEST; PREFRONTAL CORTEX; SUCROSE PREFERENCE TEST; ANIMAL; BRAIN CHEMISTRY; DOSE RESPONSE; DRUG EFFECTS; INFLAMMATION; METABOLISM;

ANIMALS; ANTIDEPRESSIVE AGENTS; BRAIN CHEMISTRY; CYTOKINES; DEPRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; HESPERIDIN; INFLAMMATION; LIPOPOLYSACCHARIDES; METABOLIC NETWORKS AND PATHWAYS; MICE; MICRORNAS;

EID: 84976868777     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-016-0402-7     Document Type: Article

References (40)

1. Howren, M.B., D.M. Lamkin, and J. Suls. 2009. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosomatic Medicine 71: 171–186.
2. Al-Hakeim, H.K., D.A. Al-Rammahi, and A.H. Al-Dujaili. 2015. IL-6, IL-18, sIL-2R, and TNFalpha proinflammatory markers in depression and schizophrenia patients who are free of overt inflammation. Journal of Affective Disorders 182: 106–114.
3. Gupta, R., K. Gupta, A.K. Tripathi, M.S. Bhatia, and L.K. Gupta. 2016. Effect of mirtazapine treatment on serum levels of brain-derived neurotrophic factor and tumor necrosis factor-alpha in patients of major depressive disorder with severe depression. Pharmacology 97: 184–188.
4. Hashimoto, T., et al. 2015. Milnacipran treatment and potential biomarkers in depressed patients following an initial SSRI treatment failure: a prospective, open-label, 24-week study. Neuropsychiatric Disease and Treatment 11: 3031–3040.
5. Li, R., D. Zhao, R. Qu, Q. Fu, and S. Ma. 2015. The effects of apigenin on lipopolysaccharide-induced depressive-like behavior in mice. Neuroscience Letters 594: 17–22.
6. Ge, L., L. Liu, H. Liu, S. Liu, H. Xue, X. Wang, L. Yuan, Z. Wang, and D. Liu. 2015. Resveratrol abrogates lipopolysaccharide-induced depressive-like behavior, neuroinflammatory response, and CREB/BDNF signaling in mice. European Journal of Pharmacology 768: 49–57.
7. Shaked, I., A. Meerson, Y. Wolf, R. Avni, D. Greenberg, A. Gilboa-Geffen, and H. Soreq. 2009. MicroRNA-132 potentiates cholinergic anti-inflammatory signaling by targeting acetylcholinesterase. Immunity 31: 965–973.
8. Yi, L.T., J. Li, B.B. Liu, L. Luo, Q. Liu, and D. Geng. 2014. BDNF-ERK-CREB signalling mediates the role of miR-132 in the regulation of the effects of oleanolic acid in male mice. Journal of Psychiatry & Neuroscience 39: 348–359.
9. Chang, C.Y., T.Y. Lin, C.W. Lu, S.K. Huang, Y.C. Wang, S.S. Chou, and S.J. Wang. 2015. Hesperidin inhibits glutamate release and exerts neuroprotection against excitotoxicity induced by kainic acid in the hippocampus of rats. Neurotoxicology 50: 157–169.
10. Justin Thenmozhi, A., T.R. Raja, U. Janakiraman, and T. Manivasagam. 2015. Neuroprotective effect of hesperidin on aluminium chloride induced Alzheimer’s disease in Wistar rats. Neurochemical Research 40: 767–776.
11. Antunes, M.S., A.T. Goes, S.P. Boeira, M. Prigol, and C.R. Jesse. 2014. Protective effect of hesperidin in a model of Parkinson’s disease induced by 6-hydroxydopamine in aged mice. Nutrition 30: 1415–1422.
12. Oztanir, M.N., O. Ciftci, A. Cetin, and M.A. Aladag. 2014. Hesperidin attenuates oxidative and neuronal damage caused by global cerebral ischemia/reperfusion in a C57BL/J6 mouse model. Neurological Sciences 35: 1393–1399.
13. Souza, L.C., M.G. de Gomes, A.T. Goes, L. Del Fabbro, C.B. Filho, S.P. Boeira, and C.R. Jesse. 2013. Evidence for the involvement of the serotonergic 5-HT(1A) receptors in the antidepressant-like effect caused by hesperidin in mice. Progress in Neuro-Psychopharmacology & Biological Psychiatry 40: 103–109.
14. Filho, C.B., L. Del Fabbro, M.G. de Gomes, A.T. Goes, L.C. Souza, S.P. Boeira, and C.R. Jesse. 2013. Kappa-opioid receptors mediate the antidepressant-like activity of hesperidin in the mouse forced swimming test. European Journal of Pharmacology 698: 286–291.
15. Donato, F., M.G. de Gomes, A.T. Goes, C.B. Filho, L. Del Fabbro, M.S. Antunes, L.C. Souza, S.P. Boeira, and C.R. Jesse. 2014. Hesperidin exerts antidepressant-like effects in acute and chronic treatments in mice: possible role of l-arginine-NO-cGMP pathway and BDNF levels. Brain Research Bulletin 104: 19–26.
16. Donato, F., et al. 2015. Evidence for the involvement of potassium channel inhibition in the antidepressant-like effects of hesperidin in the tail suspension test in mice. Journal of Medicinal Food 18: 818–823.
17. El-Marasy, S.A., H.M. Abdallah, S.M. El-Shenawy, A.S. El-Khatib, O.A. El-Shabrawy, and S.A. Kenawy. 2014. Anti-depressant effect of hesperidin in diabetic rats. Canadian Journal of Physiology and Pharmacology 92: 945–952.
18. Liu, X.X., et al. 2015. Hesperidin ameliorates lipopolysaccharide-induced acute lung injury in mice by inhibiting HMGB1 release. International Immunopharmacology 25: 370–376.
19. Kaur, G., N. Tirkey, and K. Chopra. 2006. Beneficial effect of hesperidin on lipopolysaccharide-induced hepatotoxicity. Toxicology 226: 152–160.
20. Ho, S.C., and C.T. Kuo. 2014. Hesperidin, nobiletin, and tangeretin are collectively responsible for the anti-neuroinflammatory capacity of tangerine peel (Citri reticulatae pericarpium). Food and Chemical Toxicology 71: 176–182.
21. Li, C., C. Zug, H. Qu, H. Schluesener, and Z. Zhang. 2015. Hesperidin ameliorates behavioral impairments and neuropathology of transgenic APP/PS1 mice. Behavioural Brain Research 281: 32–42.
22. O'Connor, J.C., Lawson, M.A., André, C., Moreau, M., Lestage, J., Castanon, N., Kelley, K.W., Dantzer, R. 2009. Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice. Molecular Psychiatry. 14: 511–522.
23. Porsolt, R.D., A. Bertin, and M. Jalfre. 1977. Behavioral despair in mice: a primary screening test for antidepressants. Archives Internationales de Pharmacodynamie et de Thérapie 229: 327–336.
24. Dantzer, R., J.C. O’Connor, G.G. Freund, R.W. Johnson, and K.W. Kelley. 2008. From inflammation to sickness and depression: when the immune system subjugates the brain. Nature Reviews Neuroscience 9: 46–56.
25. Cai, L., R. Li, Q.Q. Wu, and T.N. Wu. 2013. [Effect of hesperidin on behavior and HPA axis of rat model of chronic stress-induced depression]. Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica 38: 229–233.
26. Hernandez, M.E., D. Mendieta, M. Perez-Tapia, R. Bojalil, I. Estrada-Garcia, S. Estrada-Parra, and L. Pavon. 2013. Effect of selective serotonin reuptake inhibitors and immunomodulator on cytokines levels: an alternative therapy for patients with major depressive disorder. Clinical & Developmental Immunology 2013: 267871.
27. Silverman, M.N., and E.M. Sternberg. 2012. Glucocorticoid regulation of inflammation and its functional correlates: from HPA axis to glucocorticoid receptor dysfunction. Annals of the New York Academy of Sciences 1261: 55–63.
28. Walker, A.K., D.P. Budac, S. Bisulco, A.W. Lee, R.A. Smith, B. Beenders, K.W. Kelley, and R. Dantzer. 2013. NMDA receptor blockade by ketamine abrogates lipopolysaccharide-induced depressive-like behavior in C57BL/6 J mice. Neuropsychopharmacology 38: 1609–1616.
29. Zhao, Y., Y. Zhang, and F. Pan. 2015. The effects of EGb761 on lipopolysaccharide-induced depressive-like behaviour in C57BL/6 J mice. Central-European journal of immunology 40: 11–17.
30. Dantzer, R., J.C. O’Connor, M.A. Lawson, and K.W. Kelley. 2011. Inflammation-associated depression: from serotonin to kynurenine. Psychoneuroendocrinology 36: 426–436.
31. Wang, N., H.Y. Yu, X.F. Shen, Z.Q. Gao, C. Yang, J.J. Yang, and G.F. Zhang. 2015. The rapid antidepressant effect of ketamine in rats is associated with down-regulation of pro-inflammatory cytokines in the hippocampus. Upsala Journal of Medical Sciences 120: 241–248.
32. Du, R.W., R.H. Du, and W.G. Bu. 2014. beta-Arrestin 2 mediates the anti-inflammatory effects of fluoxetine in lipopolysaccharide-stimulated microglial cells. Journal of Neuroimmune Pharmacology 9: 582–590.
33. Hansen, K.F., K. Karelina, K. Sakamoto, G.A. Wayman, S. Impey, and K. Obrietan. 2013. miRNA-132: a dynamic regulator of cognitive capacity. Brain Structure & Function 218: 817–831.
34. Marler, K.J., et al. 2014. BDNF promotes axon branching of retinal ganglion cells via miRNA-132 and p250GAP. The Journal of Neuroscience 34: 969–979.
35. Marques-Rocha, J.L., M. Samblas, F.I. Milagro, J. Bressan, J.A. Martinez, and A. Marti. 2015. Noncoding RNAs, cytokines, and inflammation-related diseases. FASEB Journal 29: 3595–3611.
36. Pan, B., and Y. Liu. 2015. Effects of duloxetine on microRNA expression profile in frontal lobe and hippocampus in a mouse model of depression. International Journal of Clinical and Experimental Pathology 8: 15454–15461.
37. Fan, G., X. Jiang, X. Wu, P.A. Fordjour, L. Miao, H. Zhang, Y. Zhu, and X. Gao. 2016. Anti-inflammatory activity of Tanshinone IIA in LPS-stimulated RAW264.7 macrophages via miRNAs and TLR4-NF-kappaB pathway. Inflammation 39: 375–384.
38. Fen, L., J. Rong, Z. Zhenguo, Z. Ning, X. Liang, N. Cheng, and Q. Kejian. 2014. The expression changes in microRNA-132 in the lipopolysaccharide-induced inflammation of rat alveolar macrophages. Zhonghua wei zhong bing ji jiu yi xue 26: 80–83.
39. Liu, F., et al. 2015. miR-132 inhibits lipopolysaccharide-induced inflammation in alveolar macrophages by the cholinergic anti-inflammatory pathway. Experimental Lung Research 41: 261–269.
40. Kong, H., F. Yin, F. He, A. Omran, L. Li, T. Wu, Y. Wang, and J. Peng. 2015. The Effect of miR-132, miR-146a, and miR-155 on MRP8/TLR4-induced astrocyte-related inflammation. Journal of Molecular Neuroscience 57: 28–37.